1、$Ptc Therapeutics(PTCT)$ 财报发布,是否有重返巅峰机会?
2、 哪些RNA疗法公司有配置机会?
3、潜在肿瘤领域并购标的有哪些?$美国生科ETF-SPDR(XBI)$ $辉瑞(PFE)$查看全文
PTC Therapeutics(PTCT.US)获高盛首次覆盖,给予卖出评级, 目标价35.00美元。 PTC Therapeutics(PTCT.US)公司简介:PTC Therapeutics Inc 是一家专注于口服给药的小分子疗法的发现、开发和商业化的全球生物制药公司。公司的目标区域是当 R... 网页链接
$Ptc Therapeutics(PTCT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-005782 Act: 34 Size: 12 MB 网页链接
$Ptc Therapeutics(PTCT)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001558370-24-005767 Act: 34 Size: 390 KB 网页链接
$Ptc Therapeutics(PTCT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011329 Size: 5 KB 网页链接
$Ptc Therapeutics(PTCT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011247 Size: 5 KB 网页链接
$Ptc Therapeutics(PTCT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011248 Size: 4 KB 网页链接
$Ptc Therapeutics(PTCT)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002994 Act: 33 Size: 5 KB 网页链接
$Ptc Therapeutics(PTCT)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002969 Act: 33 Size: 5 KB 网页链接
$Ptc Therapeutics(PTCT)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002965 Act: 33 Size: 4 KB 网页链接
$Ptc Therapeutics(PTCT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010313 Size: 4 KB 网页链接
$Ptc Therapeutics(PTCT)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002765 Act: 33 Size: 5 KB 网页链接